JPMorgan Starts Sage Therapeutics (SAGE) at Overweight
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 29
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 6 | New: 29
Join SI Premium – FREE
JPMorgan initiated coverage on Sage Therapeutics (NASDAQ: SAGE) with an Overweight rating and a price target of $42.00.
For an analyst ratings summary and ratings history on Sage Therapeutics click here. For more ratings news on Sage Therapeutics click here.
Shares of Sage Therapeutics closed at $33.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Metlen Energy & Metals (MTLN:LN) at Overweight
- Oppenheimer Starts Pacira Pharmaceuticals (PCRX) at Outperform
- Oppenheimer Starts Vanda Pharmaceuticals (VNDA) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
